795.0K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 12,529 | 430,621 | - | 8.5 | 106,872 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 3,756 | 142,004 | - | 8.5 | 32,039 | Common Stock |
| Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 3,756 | 136,895 | - | 8.5 | 32,039 | Common Stock |
| Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 4,895 | 174,164 | - | 8.5 | 41,754 | Common Stock |
| Mary Kay Fenton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Mary Kay Fenton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 60,000 | 60,000 | - | 0 | Common Stock | |
| Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | |
| Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 180,000 | 443,150 | - | 0 | Common Stock | |
| Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 50,000 | 145,760 | - | 0 | Common Stock | |
| Corinne Savill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Corinne Savill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 37,500 | 240,990 | - | 0 | Common Stock | |
| Jacquelyn L. Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 50,000 | 140,651 | - | 0 | Common Stock | |
| Jacquelyn L. Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 65,000 | 179,059 | - | 0 | Common Stock | |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 06 Jan 2025 | 4,000 | 95,760 | - | 12.5 | 50,040 | Common Stock |
| Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.87 per share. | 24 Dec 2024 | 8,400 | 263,150 | - | 11.9 | 99,708 | Common Stock |
| Jeffrey Jones Alan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 18 Dec 2024 | 4,632 | 114,059 | - | 11.4 | 52,851 | Common Stock |
| Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 18 Dec 2024 | 3,482 | 90,651 | - | 11.4 | 39,730 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 18 Dec 2024 | 4,693 | 99,760 | - | 11.4 | 53,547 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 12 Dec 2024 | 3,489 | 104,453 | - | 12.5 | 43,682 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.64 per share. | 05 Nov 2024 | 8,000 | 107,942 | - | 15.6 | 125,120 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 05 Sep 2024 | 8,000 | 115,942 | - | 18.1 | 144,720 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.33 per share. | 05 Jul 2024 | 8,000 | 123,942 | - | 16.3 | 130,640 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 9.00 per share. | 01 Jul 2024 | 2,360 | 131,942 | - | 9 | 21,240 | Common Stock |
| Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 15,806 | 15,806 | - | - | Stock Option (Right to Buy) | |
| Anthony Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 15,806 | 15,806 | - | - | Stock Option (Right to Buy) | |
| Anne-Marie Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 15,806 | 15,806 | - | - | Stock Option (Right to Buy) | |
| David P. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 15,806 | 15,806 | - | - | Stock Option (Right to Buy) | |
| Thomas Ebeling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.00 per share. | 10 Jun 2024 | 18,450 | 186,653 | - | 13 | 239,850 | Common Stock |
| Thomas Ebeling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 18,450 | 0 | - | - | Stock Option (Right to Buy) | |
| Thomas Ebeling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 16,475 | 0 | - | - | Stock Option (Right to Buy) | |
| Thomas Ebeling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 84,224 | 0 | - | - | Stock Option (Right to Buy) | |
| Thomas Ebeling | Director | Grant, award, or other acquisition of securities at price $ 12.73 per share. | 23 May 2024 | 16,475 | 168,203 | - | 12.7 | 209,727 | Common Stock |
| Thomas Ebeling | Director | Grant, award, or other acquisition of securities at price $ 4.30 per share. | 23 May 2024 | 84,224 | 151,728 | - | 4.3 | 362,163 | Common Stock |
| David D. Meek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 15,618 | 15,618 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 May 2024 | 50,000 | 187,582 | - | 4.3 | 215,000 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 5,606 | 132,987 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 50,000 | 138,593 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 06 May 2024 | 5,606 | 129,582 | - | 30.1 | 168,516 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 May 2024 | 5,606 | 135,188 | - | 4.3 | 24,106 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.54 per share. | 06 May 2024 | 20,277 | 129,582 | - | 28.5 | 578,706 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.82 per share. | 06 May 2024 | 37,723 | 149,859 | - | 27.8 | 1,049,454 | Common Stock |
| Mary Kay Fenton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 50,000 | 133,919 | - | 0 | Common Stock | |
| L. Jacquelyn Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Jacquelyn Sumer L. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 50,000 | 94,133 | - | 0 | Common Stock | |
| Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ahmed Nadim | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 160,000 | 271,550 | - | 0 | Common Stock | |
| Corinne Savill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 37,500 | 203,490 | - | 0 | Common Stock | |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Savill Corinne | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Ahmed Nadim | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 50,000 | 137,582 | - | 0 | Common Stock | |
| Jones Alan Jeffrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 62,500 | 118,691 | - | 0 | Common Stock | |
| Alan Jones Jeffrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Savill Corinne | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 16.18 per share. | 01 Feb 2024 | 40,000 | 165,990 | - | 16.2 | 647,200 | Common Stock |
| Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 40,000 | 70,331 | - | - | Stock Option (Right to Buy) | |
| Corinne Savill | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 01 Feb 2024 | 40,000 | 205,990 | - | 4.3 | 172,000 | Common Stock |
| Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 29 Jan 2024 | 40,000 | 205,990 | - | 4.3 | 172,000 | Common Stock |
| Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 26,003 | 110,331 | - | - | Stock Option (Right to Buy) | |
| Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 13,997 | 0 | - | - | Stock Option (Right to Buy) | |
| Savill Corinne | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.09 per share. | 29 Jan 2024 | 40,000 | 165,990 | - | 14.1 | 563,600 | Common Stock |
| Corinne Savill | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.18 per share. | 22 Jan 2024 | 14,559 | 170,115 | - | 12.2 | 177,329 | Common Stock |
| Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 22 Jan 2024 | 21,316 | 187,306 | - | 4.3 | 91,659 | Common Stock |
| Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 22 Jan 2024 | 14,559 | 184,674 | - | 4.3 | 62,604 | Common Stock |
| Corinne Savill | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.46 per share. | 22 Jan 2024 | 21,316 | 165,990 | - | 12.5 | 265,597 | Common Stock |
| Corinne Savill | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 22 Jan 2024 | 4,125 | 165,990 | - | 12.0 | 49,583 | Common Stock |
| Savill Corinne | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 21,316 | 13,997 | - | - | Stock Option (Right to Buy) | |
| Corinne Savill | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 14,559 | 35,313 | - | - | Stock Option (Right to Buy) | |
| Ahmed Nadim | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.24 per share. | 26 Dec 2023 | 4,272 | 111,550 | - | 9.2 | 39,473 | Common Stock |
| Jacquelyn Sumer L. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,400 | 44,133 | - | 8.5 | 11,900 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,920 | 83,919 | - | 8.5 | 16,320 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,145 | 87,582 | - | 8.5 | 9,733 | Common Stock |
| Jones Jeffrey Alan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,860 | 56,191 | - | 8.5 | 15,810 | Common Stock |
| Jacquelyn Sumer L. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 290 | 45,533 | - | 8.2 | 2,384 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 398 | 85,839 | - | 8.2 | 3,272 | Common Stock |
| Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 238 | 88,727 | - | 8.2 | 1,956 | Common Stock |
| Jones Alan Jeffrey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 386 | 58,051 | - | 8.2 | 3,173 | Common Stock |
| Michaelson Jennifer | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 12 Dec 2023 | 1,068 | 88,965 | - | 7.8 | 8,341 | Common Stock |
| Trigilio Jeffrey | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 12 Dec 2023 | 1,926 | 86,237 | - | 7.8 | 15,042 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 9.08 per share. | 30 Jun 2023 | 2,340 | 88,163 | - | 9.1 | 21,247 | Common Stock |
| Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.40 per share. | 28 Jun 2023 | 759 | 115,822 | - | 11.4 | 8,653 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 399 | 85,823 | - | 12.9 | 5,163 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 238 | 90,033 | - | 12.9 | 3,080 | Common Stock |
| Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 291 | 45,823 | - | 12.9 | 3,766 | Common Stock |
| Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 387 | 58,437 | - | 12.9 | 5,008 | Common Stock |
| Thomas Ebeling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,450 | 18,450 | - | - | Stock Option (Right to Buy) | |
| Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,450 | 18,450 | - | - | Stock Option (Right to Buy) | |
| Anthony Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,450 | 18,450 | - | - | Stock Option (Right to Buy) | |
| Anne-Marie Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,450 | 18,450 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 Jun 2023 | 11,900 | 102,347 | - | 4.3 | 51,170 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 100 | 188,593 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 11,900 | 188,693 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.40 per share. | 06 Jun 2023 | 100 | 90,447 | - | 12.4 | 1,240 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 Jun 2023 | 100 | 90,547 | - | 4.3 | 430 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 06 Jun 2023 | 11,900 | 90,447 | - | 12.3 | 146,489 | Common Stock |
| Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.15 per share. | 23 May 2023 | 707 | 116,581 | - | 9.1 | 6,469 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 May 2023 | 399 | 86,541 | - | 8.8 | 3,495 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 May 2023 | 239 | 90,447 | - | 8.8 | 2,094 | Common Stock |
| Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 May 2023 | 291 | 46,114 | - | 8.8 | 2,549 | Common Stock |
| Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 May 2023 | 394 | 58,824 | - | 8.8 | 3,451 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.78 per share. | 12 May 2023 | 347 | 86,940 | - | 8.8 | 3,047 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 8.78 per share. | 12 May 2023 | 193 | 90,686 | - | 8.8 | 1,695 | Common Stock |
| Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.59 per share. | 25 Apr 2023 | 716 | 117,288 | - | 10.6 | 7,582 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Apr 2023 | 398 | 87,287 | - | 10.7 | 4,263 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Apr 2023 | 238 | 90,879 | - | 10.7 | 2,549 | Common Stock |
| Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Apr 2023 | 290 | 46,405 | - | 10.7 | 3,106 | Common Stock |
| Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Apr 2023 | 392 | 59,218 | - | 10.7 | 4,198 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.22 per share. | 12 Apr 2023 | 318 | 87,685 | - | 10.2 | 3,250 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 10.22 per share. | 12 Apr 2023 | 176 | 91,117 | - | 10.2 | 1,799 | Common Stock |
| Nadim Ahmed | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.51 per share. | 23 Mar 2023 | 706 | 118,004 | - | 10.5 | 7,420 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.32 per share. | 20 Mar 2023 | 399 | 88,003 | - | 11.3 | 4,517 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 11.32 per share. | 20 Mar 2023 | 238 | 91,293 | - | 11.3 | 2,694 | Common Stock |
| Jacquelyn L. Sumer | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.32 per share. | 20 Mar 2023 | 305 | 46,695 | - | 11.3 | 3,453 | Common Stock |
| Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.32 per share. | 20 Mar 2023 | 390 | 59,610 | - | 11.3 | 4,415 | Common Stock |
| Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 211,000 | 211,000 | - | - | Stock Option (Right to Buy) | |
| Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 109,000 | 118,710 | - | 0 | Common Stock | |
| Patrick A. Baeuerle | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 38,500 | 76,000 | - | 0 | Common Stock | |
| Patrick A. Baeuerle | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 93,500 | 93,500 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 47,000 | 88,402 | - | 0 | Common Stock | |
| Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 38,500 | 91,531 | - | 0 | Common Stock | |
| Corinne Savill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 20,500 | 170,115 | - | 0 | Common Stock | |
| Corinne Savill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 41,000 | 41,000 | - | - | Stock Option (Right to Buy) | |
| Jacquelyn L. Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 93,500 | 93,500 | - | - | Stock Option (Right to Buy) | |
| Jacquelyn L. Sumer | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 47,000 | 47,000 | - | 0 | Common Stock | |
| Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 60,000 | 60,000 | - | 0 | Common Stock | |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.97 per share. | 30 Dec 2022 | 201 | 41,402 | - | 9.0 | 1,803 | Common Stock |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 13.30 per share. | 25 Nov 2022 | 4,000 | 53,031 | - | 13.3 | 53,200 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 25 Nov 2022 | 4,000 | 57,031 | - | 4.3 | 17,200 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2022 | 4,000 | 200,593 | - | - | Stock Option (Right to Buy) | |
| David P. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 26,150 | 26,150 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 12.40 per share. | 27 Sep 2022 | 4,000 | 53,031 | - | 12.4 | 49,600 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 27 Sep 2022 | 4,000 | 57,031 | - | 4.3 | 17,200 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2022 | 4,000 | 204,593 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 08 Aug 2022 | 1,385 | 53,031 | - | 15.0 | 20,789 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 1,385 | 208,593 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 08 Aug 2022 | 1,385 | 54,416 | - | 4.3 | 5,956 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 25 Jul 2022 | 8,000 | 61,031 | - | 4.3 | 34,400 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 8,000 | 209,978 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 14.51 per share. | 25 Jul 2022 | 8,000 | 53,031 | - | 14.5 | 116,080 | Common Stock |
| Corinne Savill | Acting Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.06 per share. | 18 Jul 2022 | 5,042 | 164,573 | - | 15.1 | 75,933 | Common Stock |
| Corinne Savill | Acting Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.22 per share. | 18 Jul 2022 | 14,958 | 149,615 | - | 15.2 | 227,661 | Common Stock |
| Corinne Savill | Acting Chief Business Officer | Sale of securities on an exchange or to another person at price $ 13.85 per share. | 11 Jul 2022 | 200 | 169,615 | - | 13.9 | 2,770 | Common Stock |
| Corinne Savill | Acting Chief Business Officer | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 11 Jul 2022 | 39,800 | 169,815 | - | 13.3 | 530,534 | Common Stock |
| Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 10.90 per share. | 30 Jun 2022 | 1,620 | 9,710 | - | 10.9 | 17,658 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 10.90 per share. | 30 Jun 2022 | 1,451 | 41,201 | - | 10.9 | 15,816 | Common Stock |
| Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 10.90 per share. | 30 Jun 2022 | 1,620 | 53,031 | - | 10.9 | 17,658 | Common Stock |
| Morana Jovan-Embiricos | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 24 Jun 2022 | 104,845 | 217,352 | - | 4.3 | 450,834 | Common Stock |
| Morana Jovan-Embiricos | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 24 Jun 2022 | 35,529 | 252,881 | - | 4.3 | 152,775 | Common Stock |
| Morana Jovan-Embiricos | Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.39 per share. | 24 Jun 2022 | 45,078 | 207,803 | - | 13.4 | 603,594 | Common Stock |
| Morana Jovan-Embiricos | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 104,845 | 0 | - | - | Stock Option (Right to Buy) | |
| Morana Jovan-Embiricos | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 35,529 | 0 | - | - | Stock Option (Right to Buy) | |
| Thomas Ebeling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) | |
| Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) | |
| Anthony Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) | |
| Nadim Ahmed | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 12.40 per share. | 06 Jun 2022 | 8,090 | 8,090 | - | 12.4 | 100,316 | Common Stock |
| Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2022 | 215,000 | 215,000 | - | - | Performance Stock Unit | |
| Anne-Marie Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 36,880 | 36,880 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Patrick A. Baeuerle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 37,500 | 37,500 | - | 0 | Common Stock | |
| Patrick A. Baeuerle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Raymond T. Keane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 22,500 | 24,124 | - | 0 | Common Stock | |
| Raymond T. Keane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 37,500 | 39,750 | - | 0 | Common Stock | |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 28,500 | 51,411 | - | 0 | Common Stock | |
| Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 57,000 | 57,000 | - | - | Stock Option (Right to Buy) | |
| Corinne Savill | Acting Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Corinne Savill | Acting Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 16,500 | 209,615 | - | 0 | Common Stock | |
| Leigh Zawel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Leigh Zawel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 32,500 | 69,785 | - | 0 | Common Stock | |
| Nadim Ahmed | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 2,710,000 | 2,710,000 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 18 Oct 2021 | 4,000 | 26,911 | - | 4.3 | 17,200 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2021 | 4,000 | 217,978 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 23.61 per share. | 18 Oct 2021 | 400 | 22,911 | - | 23.6 | 9,444 | Common Stock |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 22.40 per share. | 18 Oct 2021 | 204 | 23,311 | - | 22.4 | 4,570 | Common Stock |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 21.10 per share. | 18 Oct 2021 | 3,396 | 23,515 | - | 21.1 | 71,656 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 15 Oct 2021 | 8,000 | 2,250 | - | 25 | 200,000 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2021 | 8,000 | 229,891 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Trigilio | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 15 Oct 2021 | 8,000 | 10,250 | - | 4.3 | 34,400 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 15 Oct 2021 | 19,574 | 37,285 | - | 25 | 489,350 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 07 Oct 2021 | 1,079 | 56,859 | - | 25 | 26,975 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 20 Sep 2021 | 4,000 | 26,911 | - | 4.3 | 17,200 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2021 | 4,000 | 221,978 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 25.20 per share. | 20 Sep 2021 | 800 | 22,911 | - | 25.2 | 20,160 | Common Stock |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 24.34 per share. | 20 Sep 2021 | 3,200 | 23,711 | - | 24.3 | 77,888 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 25.16 per share. | 20 Sep 2021 | 7,468 | 57,938 | - | 25.2 | 187,895 | Common Stock |
| Patrick A. Baeuerle | See Remarks | Sale of securities on an exchange or to another person at price $ 28.45 per share. | 08 Sep 2021 | 11,000 | 0 | - | 28.5 | 312,950 | Common Stock |
| Patrick A. Baeuerle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2021 | 11,000 | 240,114 | - | - | Stock Option (Right to Buy) | |
| Patrick A. Baeuerle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 08 Sep 2021 | 11,000 | 11,000 | - | 4.3 | 47,300 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.83 per share. | 08 Sep 2021 | 5,487 | 11,763 | - | 27.8 | 152,703 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2021 | 15,000 | 237,891 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Trigilio | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.85 per share. | 08 Sep 2021 | 9,513 | 2,250 | - | 28.8 | 274,450 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 08 Sep 2021 | 15,000 | 17,250 | - | 4.3 | 64,500 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 28.95 per share. | 07 Sep 2021 | 28,118 | 65,406 | - | 28.9 | 814,016 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 23 Aug 2021 | 28,118 | 93,524 | - | 29 | 815,422 | Common Stock |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 28.07 per share. | 18 Aug 2021 | 1,137 | 22,911 | - | 28.1 | 31,916 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 18 Aug 2021 | 4,000 | 26,911 | - | 4.3 | 17,200 | Common Stock |
| Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 18 Aug 2021 | 2,863 | 24,048 | - | 27.5 | 78,733 | Common Stock |
| Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2021 | 4,000 | 225,978 | - | - | Stock Option (Right to Buy) | |
| Patrick A. Baeuerle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 11,000 | 251,114 | - | - | Stock Option (Right to Buy) | |
| Patrick A. Baeuerle | See Remarks | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 10 Aug 2021 | 11,000 | 0 | - | 27 | 297,000 | Common Stock |
| Patrick A. Baeuerle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 10 Aug 2021 | 11,000 | 11,000 | - | 4.3 | 47,300 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 27.34 per share. | 09 Aug 2021 | 3,191 | 123,459 | - | 27.3 | 87,242 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 28.49 per share. | 09 Aug 2021 | 1,817 | 121,642 | - | 28.5 | 51,766 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 26.52 per share. | 09 Aug 2021 | 19,504 | 130,256 | - | 26.5 | 517,246 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 27.11 per share. | 09 Aug 2021 | 1,700 | 128,556 | - | 27.1 | 46,087 | Common Stock |
| Leigh Zawel | See Remarks | Sale of securities on an exchange or to another person at price $ 26.50 per share. | 09 Aug 2021 | 1,906 | 126,650 | - | 26.5 | 50,509 | Common Stock |
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 3,205,128 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 1,282,051 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 1,511,966 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 503,988 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 1,007,977 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 1,136,525 | 1,136,525 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 2,912,345 | 2,912,345 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 639,295 | 639,295 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 455,338 | 455,338 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 182,135 | 182,135 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 71,599 | 526,937 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 143,198 | 325,333 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 71,599 | 71,599 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 214,798 | 214,798 | - | - | Common Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 12 Jan 2021 | 95,238 | 622,175 | - | 21 | 1,999,998 | Common Stock |
| Morana Jovan-Embiricos | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 12 Jan 2021 | 104,762 | 104,762 | - | 21 | 2,200,002 | Common Stock |
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 8,000,000 | 0 | - | - | Series Seed Convertible Preferred Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 20,500,000 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 4,500,000 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Morana Jovan-Embiricos | Director, Ten Percent Owner | 12 Jan 2021 | 503,988 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Owen Hughes | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 12 Jan 2021 | 2,500 | 506,226 | - | 21 | 52,500 | Common Stock |
| Jeffrey Trigilio | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 12 Jan 2021 | 2,250 | 2,250 | - | 21 | 47,250 | Common Stock |
| Patrick A. Baeuerle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 286,665 | 286,665 | - | - | Stock Option (Right to Buy) | |
| Raymond T. Keane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 249,998 | 249,998 | - | - | Stock Option (Right to Buy) | |
| Jon Marc Wigginton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 116,666 | 116,666 | - | - | Stock Option (Right to Buy) | |
| Owen Hughes | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 433,332 | 433,332 | - | - | Stock Option (Right to Buy) | |
| Jeffrey Trigilio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 146,665 | 146,665 | - | - | Stock Option (Right to Buy) | |
| Jennifer Michaelson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 79,999 | 79,999 | - | - | Stock Option (Right to Buy) | |
| Leigh Zawel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 56,666 | 56,666 | - | - | Stock Option (Right to Buy) |